Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Role of hormone receptors and HER2 as prospective molecular markers for breast cancer: An update

18 Dec 2020

Abstract excerpt

This review provides an updated account on the current methods, principles and mechanism of action of therapies for the detection of molecular markers of therapeutic importance in the prognosis of breast cancer progression and recurrence, which includes estrogen receptor (ER), progesterone receptor (PR) and human epidermal growth factor receptor2 (HER2). Indeed, hormone-receptors namely, ER, PR, proto-oncogene...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Estrogen and related hormone effects
Share to HER2/EGFR in Cancer Research
Share to Monoclonal and Polyclonal Antibodies Research

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 35782984
DOI: 10.1016/j.gendis.2020.12.005

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Role of hormone receptors and HER2 as prospective molecular markers for breast cancer: An updatePMID 35782984Read ↗

Issues and updates: evaluating estrogen receptor-alpha, progesterone receptor, and HER2 in breast cancer.Semantic proximity Read ↗

The Prognosis and Predictive Value of Estrogen Negative/Progesterone Positive (ER-/PR+) Phenotype: Experience of 1159 Primary Breast Cancer from a Single Institute.Semantic proximity Read ↗

Breast Cancer: A Molecularly Heterogenous Disease Needing Subtype-Specific TreatmentsSemantic proximity Read ↗

Advances in EGFR/HER2-directed clinical research on breast cancer.Semantic proximity Read ↗

Breast cancer biomarkers and molecular medicine.Semantic proximity Read ↗

Molecular Targeting the Human Epidermal Growth Factor Receptor-2 (HER2) Genes Across Various CancerSemantic proximity Read ↗

The hormone receptor status in breast cancer and the relationship of subtypes with clinicopathological features.Semantic proximity Read ↗

Cancer Hallmarks, Biomarkers and Breast Cancer Molecular SubtypesSemantic proximity Read ↗

Molecular biology of human epidermal receptors, signaling pathways and targeted therapy against cancers: new evidences and old challengesSemantic proximity Read ↗

Breast cancer in Egypt: a review of disease presentation and detection strategies.Semantic proximity Read ↗

Molecular characterization of breast cancer cell lines by clinical immunohistochemical markersSemantic proximity Read ↗

Molecular Targeting of the Human Epidermal Growth Factor Receptor-2 (HER2) Genes across Various CancersSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.